Search research articles
Contact Us
Filters
Showing results (121-130 of 160) with videos related to
Page
of 16
Sort By:
Trials
|
April 5, 2020
Reporting of health equity considerations in cluster and individually randomized trials
Jennifer Petkovic, Janet Jull, Manosila Yoganathan, et al.
Seminars in Arthritis and Rheumatism
|
May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session
Lara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
Seminars in Arthritis and Rheumatism
|
June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition disease
Nicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
The Journal of Rheumatology
|
February 17, 2019
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report
Alí Duarte-García, Ying Ying Leung, Laura C Coates, et al.
Seminars in Arthritis and Rheumatism
|
June 28, 2021
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group
Melissa Oliver, Aruni Jayatilleke, Eveline Wu, et al.
Annals of the Rheumatic Diseases
|
October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group
Sabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism
|
June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group
Ken Cai, Amy Fuller, Yiling Zhang, et al.
The Journal of Rheumatology
|
January 17, 2019
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative
Sabrina M Nielsen, Peter Tugwell, Maarten P T de Wit, et al.
Seminars in Arthritis and Rheumatism
|
July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report
Bethan Jones, Caroline A Flurey, Susanna Proudman, et al.
The Journal of Rheumatology
|
September 3, 2017
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Joanna C Robson, Gunnar Tomasson, Nataliya Milman, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 160) with videos related to
Sort By:
Page
of 16
Trials
|
April 5, 2020
Reporting of health equity considerations in cluster and individually randomized trials
Jennifer Petkovic, Janet Jull, Manosila Yoganathan, et al.
Seminars in Arthritis and Rheumatism
|
May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session
Lara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
Seminars in Arthritis and Rheumatism
|
June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition disease
Nicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
The Journal of Rheumatology
|
February 17, 2019
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report
Alí Duarte-García, Ying Ying Leung, Laura C Coates, et al.
Seminars in Arthritis and Rheumatism
|
June 28, 2021
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group
Melissa Oliver, Aruni Jayatilleke, Eveline Wu, et al.
Annals of the Rheumatic Diseases
|
October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group
Sabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism
|
June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group
Ken Cai, Amy Fuller, Yiling Zhang, et al.
The Journal of Rheumatology
|
January 17, 2019
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative
Sabrina M Nielsen, Peter Tugwell, Maarten P T de Wit, et al.
Seminars in Arthritis and Rheumatism
|
July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report
Bethan Jones, Caroline A Flurey, Susanna Proudman, et al.
The Journal of Rheumatology
|
September 3, 2017
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Joanna C Robson, Gunnar Tomasson, Nataliya Milman, et al.
Page
of 16